SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 222 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $296,000 | +24.9% | 1,742 | -16.0% | 0.01% | +150.0% |
| Q4 2019 | $237,000 | -86.5% | 2,073 | -91.4% | 0.00% | -94.1% |
| Q1 2019 | $1,757,000 | +573.2% | 23,993 | +608.2% | 0.07% | +655.6% |
| Q3 2018 | $261,000 | +5.7% | 3,388 | -26.7% | 0.01% | -60.9% |
| Q4 2017 | $247,000 | -26.9% | 4,622 | -29.2% | 0.02% | -30.3% |
| Q2 2017 | $338,000 | -62.9% | 6,524 | -61.3% | 0.03% | -66.3% |
| Q3 2016 | $911,000 | -1.3% | 16,864 | -11.5% | 0.10% | -39.5% |
| Q2 2015 | $923,000 | +289.5% | 19,060 | +252.4% | 0.16% | +350.0% |
| Q3 2013 | $237,000 | -77.2% | 5,408 | -83.6% | 0.04% | -81.1% |
| Q2 2013 | $1,038,000 | – | 33,006 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |